MARKET

TECH

TECH

Bio-Techne Corp
NASDAQ
70.33
-1.28
-1.79%
After Hours: 70.33 0 0.00% 16:20 02/20 EST
OPEN
70.35
PREV CLOSE
71.61
HIGH
70.77
LOW
69.91
VOLUME
632.24K
TURNOVER
0
52 WEEK HIGH
89.91
52 WEEK LOW
51.66
MARKET CAP
11.06B
P/E (TTM)
50.73
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at TECH last week (0212-0216)?
Weekly Report · 2d ago
Baron Growth Fund Q4 2023 Shareholder Letter
Baron Growth Fund (the Fund) gained 7.70% for the quarter and 14.97 percent for the year ended December 31, 2023. The Fund’s primary benchmark, the Russell 2000 Growth Index, gained 12.75% in the same period.
Seeking Alpha · 3d ago
Analysts Expect FXH Will Reach $120
NASDAQ · 02/14 11:54
The 3 Best Biotech Stocks to Buy in February 2024
Three of the best biotech stocks to buy this February are Pfizer, Exelixis and Bio-Techne. The biotech sector is stable and capable of continuously providing growth over time. Pfizer is looking to redefine its future as a leader in cancer therapies. Bio- techne is a leading provider of biomedical equipment.
Investorplace · 02/13 13:00
Weekly Report: what happened at TECH last week (0205-0209)?
Weekly Report · 02/12 09:16
Bio-Techne Corp: Initial statement of beneficial ownership of securities
Press release · 02/06 00:09
Weekly Report: what happened at TECH last week (0129-0202)?
Weekly Report · 02/05 09:18
Bio-Techne: Solid Consumables Business and Strategic Investments Anchor Buy Rating Amid Sector Headwinds
Bio-Techne (TECH) was revisited by a Wall Street analyst on February 1. Analyst Puneet Souda from Leerink Partners reiterated a Buy rating on the stock and has a $85.00 price target. The company’s consumables business is projected to fuel growth in proteomics, cell and gene therapy.
TipRanks · 02/05 09:05
More
About TECH
Bio-Techne Corporation is a global life sciences company. The Company is engaged in providing tools and bioactive reagents for the research and clinical diagnostic communities. It operates through two segments: Protein Sciences and Diagnostics and Genomics. Its Protein Sciences segment develops and manufactures biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient and streamlined options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.

Webull offers BIO-TECHNE Corp stock information, including NASDAQ: TECH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TECH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TECH stock methods without spending real money on the virtual paper trading platform.